The Industrial Advisory Board (IAB) acts as an advisory body providing strategic review and counsel to the Executive Committee on the research activities of the Center. The IAB meets semi-annually to review the ATP-Bio's research programs and mechanisms for technology transfer, as well as assignments for action, disposition, and recommendations of IAB sub-committees.

Formed during Y2, the IAB meets quarterly, two of which happen at the fall Site Visit and spring Annual Meeting. IAB Chairs are Seb Giwa representing Nevada Donor Network and Uzair Rajput of Instant Systems, both Sustaining Members of the ATP-Bio Partners program. Its members include representatives of companies or organizations supporting the ATP-Bio at various membership levels. During IAB meetings, IAB members provide guidance and perspectives on the Center’s research strategy, future technology priorities, and the funding of ATP-Bio research projects. In Y3, the IAB launched ATP-Bio RFP002 SIRP: Stakeholder-Inspired Research Program to identify and sponsor areas of research of particular interest to members.

Acker ATP-Bio IAB

Jason Acker, Ph.D.
President & CEO,
Professor & Scientist, Transfusion Medicine and Cryopreservation
PanTHERA CryoSolutions

John Baust, Ph.D.
President & CEO Lead Scientist & Engineer, Founder
CPSI Biotech

Pierre Comizzoli, Ph.D., D.V.M.
Senior Program Officer for Science
Smithsonian

Liza Davis, M.S.
Vice President, Research and Development
Boston Scientific (BSCI)

John Downing, Ph.D.
Professor of Biology, Director of MN Sea Grant, Swenson College of Science and Engineering
University of Minnesota Duluth

Sebastian Eriksson Giwa, Ph.D.
Co-founder of Elevian, Ossium Health, Sylvatica Biotech, and the Organ Preservation Alliance (incubated at SU Labs at NASA Research Park)
Nevada Donor Network

 

Uzair Rajput, M.S.
Chief Operating Officer
Instant Systems

Adrienne Watson, Ph.D.
Vice President, Research and Development, Recombinetics
Founder and Chief Scientific Officer, Therillume
Recombinetics

Bradley P. Weegman, Ph.D.
Chief Executive Officer
Expanse Bio LLC